Rallybio Corporation (RLYB)
NASDAQ·Healthcare·Biotechnology
$16.00
+0.63%
Mkt Cap $56.84M
No analyst coverage available
We don't have analyst ratings or price target data for Rallybio Corporation yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.